Base de dados : MEDLINE
Pesquisa : C23.550.568.968 [Categoria DeCS]
Referências encontradas : 3448 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 345 ir para página                         

  1 / 3448 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28470162
[Au] Autor:Chae MO; Jeon HO; Kim A
[Ad] Endereço:Department of Nursing, College of Health Sciences, Cheongju University, Cheongju, Korea.
[Ti] Título:[A Structural Model for Premenstrual Coping in University Students: Based on Biopsychosocial Model].
[So] Source:J Korean Acad Nurs;47(2):257-266, 2017 Apr.
[Is] ISSN:2093-758X
[Cp] País de publicação:Korea (South)
[La] Idioma:kor
[Ab] Resumo:PURPOSE: The aims of this study were to construct a hypothetical structural model which explains premenstrual coping in university students and to test the fitness with collected data. METHODS: Participants were 206 unmarried women university students from 3 universities in A and B cities. Data were collected from March 29 until April 30, 2016 using self-report structured questionnaires and were analyzed using IBM SPSS 23.0 and AMOS 18.0. RESULTS: Physiological factor was identified as a significant predictor of premenstrual syndrome (t=6.45, p<.001). This model explained 22.1% of the variance in premenstrual syndrome. Psychological factors (t=-2.49, p=.013) and premenstrual syndrome (t=8.17, p<.001) were identified as significant predictors of premenstrual coping. Also this model explained 30.9% of the variance in premenstrual coping in university students. A physiological factors directly influenced premenstrual syndrome (ß=.41, p=.012). Premenstrual syndrome (ß=.55, p=.005) and physiological factor (ß=.23, p=.015) had significant total effects on premenstrual coping. Physiological factor did not have a direct influence on premenstrual coping, but indirectly affected it (ß=.22, p=.007). Psychological factors did not have an indirect or total effect on premenstrual coping, but directly affected it (ß=-.17, p=.036). CONCLUSION: These findings suggest that strategies to control physiological factors such as menstrual pain should be helpful to improve premenstrual syndrome symptoms. When developing a program to improve premenstrual coping ability and quality of menstrual related health, it is important to consider psychological factors including perceived stress and menstrual attitude and premenstrual syndrome.
[Mh] Termos MeSH primário: Adaptação Psicológica
Modelos Biológicos
Modelos Psicológicos
Síndrome Pré-Menstrual/psicologia
Estudantes/psicologia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Autorrelato
Apoio Social
Estresse Psicológico
Inquéritos e Questionários
Universidades
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180308
[Lr] Data última revisão:
180308
[Sb] Subgrupo de revista:IM; N
[Da] Data de entrada para processamento:170505
[St] Status:MEDLINE
[do] DOI:10.4040/jkan.2017.47.2.257


  2 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28458114
[Au] Autor:Liao H; Duan G; Liu P; Liu Y; Pang Y; Liu H; Tang L; Tao J; Wen D; Li S; Liang L; Deng D
[Ad] Endereço:Department of Radiology, First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi 530023, China.
[Ti] Título:Altered fractional amplitude of low frequency fluctuation in premenstrual syndrome: A resting state fMRI study.
[So] Source:J Affect Disord;218:41-48, 2017 Aug 15.
[Is] ISSN:1573-2517
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Premenstrual syndrome (PMS) is becoming highly prevalent among female and is characterized by emotional, physical and behavior symptoms. Previous evidence suggested functional dysregulation of female brain was expected to be involved in the etiology of PMS. The aim of present study was to evaluate the alterations of spontaneous brain activity in PMS patients based on functional magnetic resonance imaging (fMRI). METHODS: 20 PMS patients and 21 healthy controls underwent resting-state fMRI scanning during luteal phase. All participants were asked to complete a prospective daily record of severity of problems (DRSP) questionnaire. RESULTS: Compared with healthy controls, the results showed that PMS patients had increased fALFF in bilateral precuneus, left hippocampus and left inferior temporal cortex, and decreased fALFF in bilateral anterior cingulate cortex (ACC) and cerebellum at luteal phase. Moreover, the DRSP scores of PMS patients were negatively correlated with the mean fALFF in ACC and positively correlated with the fALFF in precuneus. LIMITATIONS: (1) the study did not investigate whether or not abnormal brain activity differences between groups in mid-follicular phase, and within-group changes. between phases.(2) it was relatively limited sample size and the participants were young; (3) fALFF could not provide us with more holistic information of brain network;(4) the comparisons of PMS and premenstrual dysphoric disorder (PMDD) were not involved in the study. CONCLUSIONS: The present study shows abnormal spontaneous brain activity in PMS patients revealed by fALFF, which could provide neuroimaging evidence to further improve our understanding of the underlying neural mechanism of PMS.
[Mh] Termos MeSH primário: Encéfalo/fisiopatologia
Imagem por Ressonância Magnética/métodos
Síndrome Pré-Menstrual/fisiopatologia
[Mh] Termos MeSH secundário: Adulto
Mapeamento Encefálico/métodos
Feminino
Fase Folicular
Giro do Cíngulo/fisiopatologia
Seres Humanos
Fase Luteal
Neuroimagem
Lobo Parietal/fisiopatologia
Transtorno Disfórico Pré-Menstrual/fisiopatologia
Estudos Prospectivos
Lobo Temporal
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180115
[Lr] Data última revisão:
180115
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170502
[St] Status:MEDLINE


  3 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29189192
[Au] Autor:Houghton SC; Manson JE; Whitcomb BW; Hankinson SE; Troy LM; Bigelow C; Bertone-Johnson ER
[Ad] Endereço:1Department of Biostatistics and Epidemiology,University of Massachusetts,Amherst,MA 01003,USA.
[Ti] Título:Intake of dietary fat and fat subtypes and risk of premenstrual syndrome in the Nurses' Health Study II.
[So] Source:Br J Nutr;118(10):849-857, 2017 Nov.
[Is] ISSN:1475-2662
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Approximately 8-20 % of reproductive-aged women experience premenstrual syndrome (PMS), substantially impacting quality of life. Women with PMS are encouraged to reduce fat intake to alleviate symptoms; however, its role in PMS development is unclear. We evaluated the association between dietary fat intake and PMS development among a subset of the prospective Nurses' Health Study II cohort. We compared 1257 women reporting clinician-diagnosed PMS, confirmed by premenstrual symptom questionnaire and 2463 matched controls with no or minimal premenstrual symptoms. Intakes of total fat, subtypes and fatty acids were assessed via FFQ. After adjustment for age, BMI, smoking, Ca and other factors, intakes of total fat, MUFA, PUFA and trans-fat measured 2-4 years before were not associated with PMS. High SFA intake was associated with lower PMS risk (relative risk (RR) quintile 5 (median=28·1 g/d) v. quintile 1 (median=15·1 g/d)=0·75; 95 % CI 0·58, 0·98; P trend=0·07). This association was largely attributable to stearic acid intake, with women in the highest quintile (median=7·4 g/d) having a RR of 0·75 v. those with the lowest intake (median=3·7 g/d) (95 % CI 0·57, 0·97; P trend=0·03). Individual PUFA and MUFA, including n-3 fatty acids, were not associated with risk. Overall, fat intake was not associated with higher PMS risk. High intake of stearic acid may be associated with a lower risk of developing PMS. Additional prospective research is needed to confirm this finding.
[Mh] Termos MeSH primário: Dieta
Gorduras na Dieta/farmacologia
Ácidos Graxos/farmacologia
Comportamento Alimentar
Síndrome Pré-Menstrual
[Mh] Termos MeSH secundário: Adulto
Gorduras na Dieta/efeitos adversos
Ácidos Graxos/efeitos adversos
Ácidos Graxos Monoinsaturados/efeitos adversos
Ácidos Graxos Insaturados/efeitos adversos
Feminino
Seres Humanos
Síndrome Pré-Menstrual/etiologia
Síndrome Pré-Menstrual/prevenção & controle
Estudos Prospectivos
Risco
Ácidos Esteáricos/efeitos adversos
Ácidos Esteáricos/farmacologia
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Dietary Fats); 0 (Fatty Acids); 0 (Fatty Acids, Monounsaturated); 0 (Fatty Acids, Unsaturated); 0 (Stearic Acids); 4ELV7Z65AP (stearic acid)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171213
[Lr] Data última revisão:
171213
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171201
[St] Status:MEDLINE
[do] DOI:10.1017/S0007114517002690


  4 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28802473
[Au] Autor:Chiaramonte D; Ring M; Locke AB
[Ad] Endereço:Department of Family and Community Medicine, Center for Integrative Medicine, University of Maryland School of Medicine, 520 West Lombard Street, East Hall, Baltimore, MD 21201, USA; Department of Epidemiology and Public Health, Center for Integrative Medicine, University of Maryland School of Medicine, 520 West Lombard Street, East Hall, Baltimore, MD 21201, USA. Electronic address: dchiaramonte@som.umaryland.edu.
[Ti] Título:Integrative Women's Health.
[So] Source:Med Clin North Am;101(5):955-975, 2017 Sep.
[Is] ISSN:1557-9859
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This article addresses the common women's health concerns of menopause-related symptoms, premenstrual syndrome, and chronic pelvic pain. Each can be effectively addressed with an integrative approach that incorporates interventions such as pharmaceuticals, nutraceuticals, mind-body approaches, acupuncture, and lifestyle modification.
[Mh] Termos MeSH primário: Terapias Complementares/métodos
Doenças dos Genitais Femininos/terapia
Medicina Integrativa/métodos
Menopausa
Síndrome Pré-Menstrual/terapia
[Mh] Termos MeSH secundário: Peso Corporal
Doença Crônica
Cistite Intersticial/terapia
Dieta
Terapia de Reposição de Estrogênios/métodos
Feminino
Comportamentos Relacionados com a Saúde
Seres Humanos
Estilo de Vida
Terapias Mente-Corpo/métodos
Dor Pélvica/terapia
Fitoterapia/métodos
Transtorno Disfórico Pré-Menstrual/terapia
Vulvodinia/terapia
Saúde da Mulher
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170823
[Lr] Data última revisão:
170823
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170814
[St] Status:MEDLINE


  5 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28682101
[Au] Autor:Pang RD; Andrabi N; Leventhal AM
[Ad] Endereço:Department of Preventive Medicine, University of Southern California Keck School of Medicine.
[Ti] Título:Premenstrual symptoms and factors implicated in smoking cessation among woman smokers.
[So] Source:Exp Clin Psychopharmacol;25(4):235-241, 2017 Aug.
[Is] ISSN:1936-2293
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Premenstrual symptoms (PMS) may reduce smoking cessation success. Yet, little is known about the factors that may impact smoking cessation among women with elevated PMS, leaving little data to guide smoking cessation science and practice for this population. This cross-sectional study is a secondary analysis of data from laboratory studies focused on menstrual cycle effects and smoking. Premenopausal woman daily smokers (n = 157) completed self-report measures of tobacco dependence and other cessation-relevant factors (i.e., smoking cessation history, withdrawal during previous quit attempts, use of smoking cessation aids) as well as a measure assessing 3 domains of PMS-affective, water retention, and pain. After controlling for depression and race, affective PMS were associated with greater daytime tobacco dependence, withdrawal symptoms during most recent quit attempt, and number of smoking cessation aids used in past quit attempts (ßs = .19-.28, ps < .05). Additionally, affective PMS were associated with increased odds of having used e-cigarettes during past quit attempts (odds ratio = 1.54, 95% confidence interval [1.06, 2.24]) after adjusting for depression and race. These results across different domains of PMS suggest that affective PMS may play a particularly important role in smoking cessation. Women with elevated affective PMS may be more inclined to try cessation aids and require special clinical attention to controlling tobacco withdrawal during quit attempts to increase success. (PsycINFO Database Record
[Mh] Termos MeSH primário: Ciclo Menstrual/fisiologia
Síndrome Pré-Menstrual/complicações
Abandono do Hábito de Fumar/métodos
Prevenção do Hábito de Fumar
[Mh] Termos MeSH secundário: Adolescente
Adulto
Estudos Transversais
Feminino
Seres Humanos
Síndrome de Abstinência a Substâncias/epidemiologia
Tabagismo/reabilitação
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:171116
[Lr] Data última revisão:
171116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170707
[St] Status:MEDLINE
[do] DOI:10.1037/pha0000132


  6 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28481623
[Au] Autor:Matsumoto T; Kimura T; Hayashi T
[Ad] Endereço:1 Department of Health Education, Faculty of Education, Shitennoji University , Osaka, Japan .
[Ti] Título:Does Japanese Citrus Fruit Yuzu (Citrus junos Sieb. ex Tanaka) Fragrance Have Lavender-Like Therapeutic Effects That Alleviate Premenstrual Emotional Symptoms? A Single-Blind Randomized Crossover Study.
[So] Source:J Altern Complement Med;23(6):461-470, 2017 Jun.
[Is] ISSN:1557-7708
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: A majority of menstruating women experience some degree of regular recurrences of diverse symptoms-commonly known as premenstrual syndrome (PMS)-during the days before menstruation. Given the multifactorial etiology of PMS, no single treatment is universally recognized as effective, and many women turn to alternative modalities, including aromatherapy. The present study investigated therapeutic effects on premenstrual symptoms using fragrance from yuzu, a Japanese citrus fruit (Citrus junos Sieb. ex Tanaka), and aromatherapy, from the perspective of autonomic nervous system function. SUBJECTS: Seventeen women in their 20s with subjective premenstrual symptoms. DESIGN: A single-blind randomized crossover study. SETTINGS/LOCATION: This study was performed at a laboratory in a university in Osaka, Japan. Subjects were examined on two separate occasions in the luteal phase. OUTCOME MEASURES: Using two aromatic stimulation sources (yuzu and lavender used as the control), this experiment measured heart rate variability (HRV) reflecting autonomic nerve activity and the Profile of Mood States (POMS) as a psychologic index before and after aromatic stimulation. RESULTS: A scant 10-min inhalation of the yuzu scent significantly decreased heart rate and increased high-frequency power of HRV, reflecting parasympathetic nerve activity, in the luteal phase. Additionally, POMS tests demonstrated that inhalation of the yuzu essential oil significantly decreased three negative subscales: tension-anxiety, anger-hostility, and fatigue-common premenstrual symptoms, together with a total mood disturbance as a global measure of affective state, as long as 35 min after the aroma stimulation. These premenstrual psychoneurophysiologic effects of yuzu fragrance did not differ from those of the effects of lavender. CONCLUSIONS: The present study indicated that short-term inhalation of yuzu fragrance could alleviate premenstrual emotional symptoms, which, at least in part, is attributable to the improvement of parasympathetic nervous system activity. This study further implies that yuzu fragrance aromatherapy might serve as an anti-PMS modality, given its comparable psychoneurophysiologic effects to those of lavender, a representative relaxing scent.
[Mh] Termos MeSH primário: Aromaterapia/métodos
Citrus
Frequência Cardíaca/efeitos dos fármacos
Óleos Voláteis/uso terapêutico
Óleos Vegetais/uso terapêutico
Síndrome Pré-Menstrual/terapia
[Mh] Termos MeSH secundário: Adulto
Afeto/efeitos dos fármacos
Feminino
Seres Humanos
Olfato/fisiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Oils, Volatile); 0 (Plant Oils); ZBP1YXW0H8 (lavender oil)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170626
[Lr] Data última revisão:
170626
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170509
[St] Status:MEDLINE
[do] DOI:10.1089/acm.2016.0328


  7 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28434473
[Au] Autor:Bazarganipour F; Taghavi SA; Allan H; Beheshti F; Khalili A; Miri F; Rezaei M; Mojgori M; Imaninasab F; Irani F; Salari S
[Ad] Endereço:Hormozgan Fertility & Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
[Ti] Título:The effect of applying pressure to the LIV3 and LI4 on the symptoms of premenstrual syndrome: A randomized clinical trial.
[So] Source:Complement Ther Med;31:65-70, 2017 Apr.
[Is] ISSN:1873-6963
[Cp] País de publicação:Scotland
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To evaluate the effect of simple acupressure protocol in LIV3, LI4 and placebo points on the quality of life (QOL) in women with premenstrual syndrome (PMS). METHOD: This paper reports a randomized, single blinded clinical trial. 97 participants (students in of Hormozgan University of Medical Sciences, Iran) with PMS were allocated to three groups to receive 20min acupressure on different acupoints for 14days before menstruation for three consecutive menstrual cycles (training and then two cycles self applied acupressure). The acupoints were LIV3 and LI4; one group received acupressure at a placebo point. Each participant completed the PSST scale (to determine PMS severity), HADS scale (for depression and anxiety), and quality of life SF12. RESULTS: The number of people with moderate/severe PMS decreased in LIV3 and LI4 acupressure groups by the second and third cycles compared with the placebo group (p<0.04). Moreover, depression and anxiety scores significantly decreased in the LIV3 and LI4 groups by the second and third cycles compared with the placebo group (p<0.05).Analyzing the score of SF12 fields in the second and third cycles showed a significant difference in all dimensions between the intervention and placebo groups. There was no significant difference between LIV3 and LI4 acupressure groups in decrease of PMS symptoms, anxiety and depression and improving SF12scores (p<0.05). CONCLUSION: Performing the simple acupressure protocol at LIV3 and LI4 is an effective method to decrease the severity of PMS symptoms, anxiety and depression, and to improve the QOL. Pressure at LIV3 and LI4 appears to be equally effective.
[Mh] Termos MeSH primário: Acupressão
Pontos de Acupuntura
Síndrome Pré-Menstrual/terapia
[Mh] Termos MeSH secundário: Adolescente
Adulto
Ansiedade/terapia
Depressão/terapia
Feminino
Seres Humanos
Irã (Geográfico)
Meia-Idade
Qualidade de Vida
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170626
[Lr] Data última revisão:
170626
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170425
[St] Status:MEDLINE


  8 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28419170
[Au] Autor:Ussher JM; Perz J
[Ad] Endereço:Translational Health Research Institute (THRI), School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.
[Ti] Título:Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial.
[So] Source:PLoS One;12(4):e0175068, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:DESIGN: A randomised control trial (RCT) was conducted to examine the efficacy of couple-based cognitive behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait-list control. METHODS: Triangulation of quantitative and qualitative outcome measures evaluated changes pre-post intervention. Eighty three women were randomly allocated across three conditions, with 63 completing post-intervention measures, a retention rate of 76%. RESULTS: Repeated measures analysis of variance found a significant time by group interaction identifying that women in the two CBT conditions reported lower total premenstrual symptoms, emotional reactivity/mood, and premenstrual distress, in comparison to the wait list control. Significantly higher active behavioural coping post-intervention was found in the couple condition than in the one-to-one and wait list control groups. Qualitative analysis provided insight into the subjective experience of PMDs and participation in the intervention study. Across groups, women reported increased awareness and understanding of premenstrual change post-intervention. A larger proportion of women in the CBT conditions reported reduction in intensity and frequency of negative premenstrual emotional reactivity, increased communication and help-seeking, increased understanding and acceptance of embodied change, and the development of coping skills, post-intervention. Increased partner understanding and improved relationship post-intervention was reported by a greater proportion of participants in the CBT conditions, most markedly in the couple condition. CONCLUSION: These findings suggest that one-to-one and couple CBT interventions can significantly reduce women's premenstrual symptomatology and distress, and improve premenstrual coping. Couple based CBT interventions may have a greater positive impact upon behavioural coping and perceptions of relationship context and support. This suggests that CBT should be available for women reporting moderate-severe PMDs, with couple-based CBT offering additional benefits to a one-to-one modality.
[Mh] Termos MeSH primário: Terapia Cognitiva/métodos
Síndrome Pré-Menstrual/terapia
Inquéritos e Questionários
Listas de Espera
[Mh] Termos MeSH secundário: Adulto
Transtornos de Ansiedade/psicologia
Transtornos de Ansiedade/terapia
Transtorno Depressivo/psicologia
Transtorno Depressivo/terapia
Feminino
Seres Humanos
Síndrome Pré-Menstrual/psicologia
Qualidade de Vida
Resultado do Tratamento
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170522
[Lr] Data última revisão:
170522
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170419
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0175068


  9 / 3448 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28407153
[Au] Autor:Leahy LG
[Ti] Título:Premenstrual Exacerbations: Achieving Stability All Month, Every Month.
[So] Source:J Psychosoc Nurs Ment Health Serv;55(4):9-13, 2017 Apr 01.
[Is] ISSN:0279-3695
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Premenstrual syndrome, premenstrual dysphoric disorder, or premenstrual exacerbation of a psychiatric condition may disrupt 10 years of a woman's life over the course of her reproductive lifespan. As health care practitioners, nurses see women who experience these premenstrual symptom exacerbations in all treatment settings. Premenstrual exacerbation of psychiatric illness is a common phenomenon, and it is treatable; however, research is limited and evidence-based guidelines for treatment are sparse. The current article offers insights and an algorithm, extrapolated from the existing literature, into a lesser-known treatment strategy, semi-intermittent dosing, which will provide symptom stability all month, every month. [Journal of Psychosocial Nursing and Mental Health Services, 55(4), 9-13.].
[Mh] Termos MeSH primário: Transtornos Mentais/tratamento farmacológico
Síndrome Pré-Menstrual/tratamento farmacológico
Inibidores da Captação de Serotonina/uso terapêutico
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Transtornos Mentais/psicologia
Síndrome Pré-Menstrual/psicologia
Índice de Gravidade de Doença
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Serotonin Uptake Inhibitors)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170717
[Lr] Data última revisão:
170717
[Sb] Subgrupo de revista:IM; N
[Da] Data de entrada para processamento:170414
[St] Status:MEDLINE
[do] DOI:10.3928/02793695-20170330-02


  10 / 3448 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28392498
[Au] Autor:Parazzini F; Di Martino M; Pellegrino P
[Ad] Endereço:Fondazione IRCCS Cà Granda, Dipartimento Materno-Infantile, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Universita' di Milano, Milan, Italy.
[Ti] Título:Magnesium in the gynecological practice: a literature review.
[Ti] Título:Magnesium in the gynecological practice: a literature review..
[So] Source:Magnes Res;30(1):1-7, 2017 Feb 01.
[Is] ISSN:1952-4021
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:A growing amount of evidence suggests that magnesium deficiency may play an important role in several clinical conditions concerning women health such as premenstrual syndrome, dysmenorrhea, and postmenopausal symptoms. A number of studies highlighted a positive correlation between magnesium administration and relief or prevention of these symptoms, thus suggesting that magnesium supplementation may represent a viable treatment for these conditions. Despite this amount of evidence describing the efficacy of magnesium, few and un-systematize data are available about the pharmacological mechanism of this ion for these conditions. Herein, we review and systematize the available evidence about the use of oral magnesium supplementation in several gynecological conditions and discuss the pharmacological mechanisms that characterize these interventions. The picture that emerges indicates that magnesium supplementation is effective in the prevention of dysmenorrhea, premenstrual syndrome, and menstrual migraine and in the prevention of climacteric symptoms.
[Mh] Termos MeSH primário: Dismenorreia/tratamento farmacológico
Magnésio/uso terapêutico
Osteoporose Pós-Menopausa/tratamento farmacológico
Pós-Menopausa/efeitos dos fármacos
Síndrome Pré-Menstrual/tratamento farmacológico
[Mh] Termos MeSH secundário: Suplementos Nutricionais
Dismenorreia/metabolismo
Feminino
Seres Humanos
Magnésio/administração & dosagem
Pós-Menopausa/metabolismo
Síndrome Pré-Menstrual/metabolismo
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
I38ZP9992A (Magnesium)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170802
[Lr] Data última revisão:
170802
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170411
[St] Status:MEDLINE
[do] DOI:10.1684/mrh.2017.0419



página 1 de 345 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde